MedPath

Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke

Phase 2
Conditions
Acute Ischemic Stroke
Interventions
Drug: XSCR capsule (Composed of Traditional Chinese Medicine Huangqi, Chuanxiong, Chishao, Danggui, Dilong, Taoren, Honghua.)
Drug: Placebo
Registration Number
NCT00710164
Lead Sponsor
Fudan University
Brief Summary

This study will determine if Xiaoshuanchangrong (XSCR) capsule will improve recovery from an acute stroke. The study is designed to look at both overall recovery and recovery of motor function, for example muscle strength and coordination.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Acute ischemic stroke with limb weakness, NIH stroke scale ≥6, limb weakness score ≥2
  • Onset of symptoms within 72 hours
  • 18 Years and older
  • Consistent with the Qi deficiency and Blood stasis type by Traditional Chinese Medicine (TCM) standard
  • Patients or their representatives voluntarily take part in this study and signed the informed consent
Exclusion Criteria
  • Transient ischemic attack(TIA), cerebral hemorrhage, subarachnoid hemorrhage
  • Subjects who are unlikely to complete taking the investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
  • Pregnant or breast-feeding.
  • Proven disability by law, such as blindness, deafness, dumb, disturbance of intelligence, mental disorders, limb handicap.
  • Liable to be allergic (allergic to at lease 2 foods/drugs previously exposed)
  • Had been participated in other clinical trials during the last 1 month prior to study inclusion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AXSCR capsule (Composed of Traditional Chinese Medicine Huangqi, Chuanxiong, Chishao, Danggui, Dilong, Taoren, Honghua.)-
BPlacebo-
Primary Outcome Measures
NameTimeMethod
Global disability on modified Rankin scale90 days
Secondary Outcome Measures
NameTimeMethod
NIH stroke scale90 days
Barthel Index90 days
Syndrome score by Traditional Chinese Medicine (TCM) standard90 days
mini-mental state examination (MMSE)90 days
Changes in laboratory indexes as safety assessment, including red blood cell(RBC), white blood cell(WBC), platelet(PLT), alanine transaminase (ALT), aspartate transaminase(AST), blood urea nitrogen (BUN), creatinine(Cr) in blood samples; protein, red b90 days

Trial Locations

Locations (20)

Department of Nuerology, The Second People's Hospital of Foshan city

🇨🇳

Foshan, Guangdong, China

Department of Nuerology, Kunming General Hospital of Chengdu Military Command

🇨🇳

Kunming, Chengdu, China

Department of Nuerology, The Second People's Hospital of Jiangmen city

🇨🇳

Jiangmen, Guangdong, China

Department of Nuerology, Liuzhou Hospital of Traditional Chinese Medicine

🇨🇳

Liuzhou, Guangxi, China

Department of Nuerology, The First People's Hospital of Changsha city

🇨🇳

Changsha, Hunan, China

Department of Nuerology, Changzheng Hospital Affiliated to the Second Military Medical University

🇨🇳

Shanghai, Shanghai, China

Department of Neurology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Integrative Medicine, Zhongshan hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Cangzhou Central Hospistal

🇨🇳

Cangzhou, Hebei, China

Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Hubei Hospital of Traditional Chinese Medicine

🇨🇳

Wuhan, Hubei, China

Department of Nuerology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Neurology, Huashan hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Zhongshan hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Tongji Hospital of Tongji University

🇨🇳

Shanghai, Shanghai, China

Department of Neurology, Shanghai First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Department of Neurology, Changhai Hospital Affiliated to the Second Military Medical University

🇨🇳

Shanghai, Shanghai, China

Department of Nuerology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath